DUOX2 and cyclic hematopoiesis: We found that TCH and PCH have equal shares in patients with DUOX2 mutations, which demonstrated that monoallelic and biallelic DUOX2 mutations can both cause transient or permanent CH, while there was no correlation between the final outcome and the mutation type.